GoodRx (GDRX) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Leadership transition and strategic vision

• New CEO Wendy Barnes brings deep experience across pharma, PBM, and retail pharmacy, with a focus on leveraging industry relationships and driving disruption in the drug value chain.

• Key leadership priorities include team integration, expanding talent, and reinforcing company culture.

• Immediate focus on building relationships with retailers, pharma, PBMs, government regulators, and trade associations.

• Quick wins identified in doubling brand partnerships to 150 in 2024 and pursuing virtual pharmacy partnerships for enhanced consumer delivery options.

• Emphasis on leveraging historical relationships to reengage at senior levels with key partners.

Business model evolution and growth drivers

• Manufacturer solutions business has shifted from media-based advertising to always-on access and cash pay programs, now driving the majority of revenue.

• Revenue from manufacturer solutions grew from $17–18 million in 2020 to around $110 million in 2024, with high confidence in continued exponential growth.

• Programs deliver faster patient onboarding, higher prescription rates, and strong ROI for pharma partners.

• High-deductible health plan trends and narrowing pharmacy networks are seen as tailwinds, increasing consumer need for price transparency and savings tools.

• Direct employer engagement and broker partnerships are targeted as new growth avenues, with potential for tailored solutions for large employers.

Ecosystem partnerships and technology integration

• Strong provider engagement, with one in two U.S. healthcare providers regularly discussing the platform with patients and over 1 million prescribers actively supporting.

• Provider portal enhancements and long-term vision to integrate with EMRs for seamless price transparency at the point of care.

• Retail pharmacy partnerships focus on stabilizing margins, e-commerce integration, and supporting cost-plus models, which now account for over 30% of volume.

• Store closures at major chains have had minimal impact except in cases of concentrated closures, with most volume shifting seamlessly to other locations.

• Ongoing efforts to partner with PBMs for price transparency tools, leveraging consumer trust and independence as differentiators.